SOURCES

1
Gerber, A. N., Newton, R., & Sasse, S. K. (2021). Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics. Journal of Biological Chemistry, 296. https://doi.org/10.1016/j.jbc.2021.100687

2
Schultze, J. L., Mass, E., & Schlitzer, A. (2019). Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation. In Immunity (Vol. 50, Issue 2, pp. 288–301). Cell Press. https://doi.org/10.1016/j.immuni.2019.01.019

3
Lee, S. E., Oh, E., Lee, B., Kim, Y. J., Oh, D.-Y., Jung, K., Choi, J.-S., Kim, J., Kim, S. J., Yang, J. W., An, J., Oh, Y. L., & Choi, Y.-L. (n.d.). Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma. In Oncotarget (Vol. 7, Issue 17). www.impactjournals.com/oncotarget/

4
Joo, M., & Sadikot, R. T. (2012). PGD synthase and PGD 2 in immune response. In Mediators of Inflammation (Vol. 2012). https://doi.org/10.1155/2012/503128

5
Heuts, B. M. H., Arza-Apalategi, S., Alkema, S. G., Tijchon, E., Jussen, L., Bergevoet, S. M., van der Reijden, B. A., & Martens, J. H. A. (2023). Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation. Cells, 12(8). https://doi.org/10.3390/cells12081195

6
Schulman, E. S., Kagey-Sobotka, A., MacGlashan, D. W., Adkinson, N. F., Peters, S. P., Schleimer, R. P., & Lichtenstein, L. M. (1983). Heterogeneity of human mast cells. J Immunol, 131 (4): 1936–1941. https://doi.org/10.4049/jimmunol.131.4.1936

7
Downey, G. P., Doherty, D. E., Schwab, B. 3rd, Elson, E. L., Henson, P. M., & Worthen, G. S. (1990). Retention of leukocytes in capillaries: role of cell size and deformability. J Appl Physiol. 69(5):1767-78 p.1771 table 1.